Great Point Partners’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-101,235
Closed -$477K 38
2015
Q3
$477K Sell
101,235
-178,765
-64% -$1.15M 0.19% 35
2015
Q2
$2M Sell
280,000
-697,923
-71% -$5.25M 0.78% 28
2015
Q1
$8.28M Sell
977,923
-207,709
-18% -$1.77M 3.65% 9
2014
Q4
$11M Buy
1,185,632
+24,028
+2% +$209K 5.31% 5
2014
Q3
$9.68M Buy
1,161,604
+13,312
+1% +$123K 4.16% 7
2014
Q2
$13.3M Buy
1,148,292
+223,292
+24% +$2.29M 5.9% 3
2014
Q1
$11.7M Buy
+925,000
New +$12M 6.13% 5

Other funds holding DSCI

Great Point Partners's DSCI Position: Q4 2015 in Review

Great Point Partners sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q4 2015, closing a stake of 101,235 shares — an estimated $477K sold.

Great Point Partners first reported a position in DSCI in Q1 2014 and held it in 7 quarters. The position peaked at $13.3M in Q2 2014. 59 funds tracked by Wall St. Rank hold DSCI as of Q4 2015.

  • Great Point Partners reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q4 2015 after selling out during the quarter.
  • Great Point Partners sold 101,235 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2015, an estimated $477K.
  • Great Point Partners first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2014 and held it in 7 quarters.
  • Great Point Partners's Derma Sciences, Inc. Common Stock (DE) position peaked at $13.3M in Q2 2014.
  • 59 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2015.

Based on Great Point Partners's 13F filing for Q4 2015, filed 16 Feb 2016.